Knowledge and Practice of Adverse Drugs Reaction Reporting Among Health Care Practitioners in Primary Health Care Centers in Kano Metropolis

Abstract

Background and Aims: Adverse Drug Reactions are one of the factors that contribute to hospitalization and death and can be duly prevented and reduced through spontaneous reporting. The study aimed at assessing the knowledge and Practice of Adverse Drug Reaction Reporting among Health Care Practitioners in Primary Health Care Centers in Kano Metropolis. Methods: The cross-sectional study used a modified questionnaire that was adapted from similar previous studies with two sections. The total knowledge and practice scores were categorized as good for scores 80% and above, moderate for scores between 60-79% and poor for scores less than 60% using Bloom’s cut-off point. Pearson Chi-square and Fischer-Freeman-Halton Exact Tests, where necessary, were used to test the hypotheses with p < 0.05 set as the level of statistical significance. Results: The outcome of the study revealed that though the respondents were aware of pharmacovigilance, only a few (13; 4.4%) understood what pharmacovigilance comprehensively entails. 213(71.7%) have in¬adequate knowledge and 161(71.7%) showed adequate practice of Adverse Drug Reaction reporting. Also, the participants’ cadre significantly influences their knowledge (P-value≤ 0.026<0.05) and the knowledge of Adverse Drug Reaction significantly influences their practice of Adverse Drug Reaction reporting (P-value≤0.031< 0.05). Conclusions: Healthcare practitioners are aware of pharmacovigilance but show inadequate knowledge of pharmacovigilance and Adverse Drug Reactions. However, there is an adequate Adverse Drug Reaction reporting practice among the healthcare practitioners. There is a need for continuous mandatory training on Adverse Drug Reactions and reporting, irrespective of the cadre or years of work experience of the health workers.

References

1. 1.World Health Organisation.World Patient Safety Day [Internet]. 2022. Available from: https://www.who. int/campaigns/world-patient-safetyday/2022
2. 2.LeTT,NguyenTT,NguyenC,Tran NH, Tran LA, Nguyen TB, et al. Factors associated with spontaneous ADR reporting among healthcare professionals in Vietnam.J Clin Pharm Ther. 2020;45(1):122-127. Doi: 10.1111/ jcpt.13051
3. 3.Almandil NB. Healthcare professionals’ awareness and knowledge of adverse drug reactions and pharmacovigilance. Saudi Med J. 2016;37(12):1359-1364. Doi: 10.15537/smj.2016.12.17059 doi:10.15537/smj.2016.12.17059
4. 4.Fornasier G, Francescon S, Leone R, Baldo P. An historical overview of Pharmacovigilance. Int J Clin Pharm. 2018;40(4):744-747. Doi: 10.1007/ s11096-018-0659-4 Majmaah Journal of Health Sciences ,Vol.13, Issue1 , January-2025,Rajab -1446 25 Knowledge and Practice of Adverse Drugs Reaction ReportingAmongHealthCarePractitionersinPrimaryHealthCareCentersinKano Metropolis
5. 5.ZakaUN,NisaA,ZafarAB,Farooq SC.Assessment of knowledge,attitude and practice of ADR reporting among healthcare professionals in secondary and tertiary hospitals in the capital of Pakistan.Saudi Pharm J.2018;26:453-
6. 6.Doi: 10.1016/j.jsps.2017.08.015 doi:10.1016/j.jsps.2017.08.015
7. 7.NationalAgencyforFoodandDrug Administration and Control (NAF- DAC). Safety of medicines in Nigeria: a guide for detecting and reporting adversedrugreactions:whyhealthprofessionals need to act.Nigeria:NAFDAC; 2004. OCLC 191684385
8. 8.Nisa ZU, Zafar A, Sher F. Assessment of knowledge, attitude and practice of adverse drug reaction reporting among healthcare professionals in secondary and tertiary hospitals in the capital of Pakistan. Saudi Pharm J. 2018;26(4):453-461. Doi: 10.1016/j. jsps.2017.08.015 doi:10.1016/j
9. 9.Mouton JP, Njuguna C, Kramer N, Stewart A, Mehta U, Blockman M, et al. Adverse drug reactions causing admission to medical wards: a cross-sectional survey at 4 hospitals in South Africa. Medicine (Baltimore). 2016;95(19):e3437. Doi: 10.1097/ MD.0000000000003437
10. 10.Oshikoya KA, Chukwura H, Njokanma OF, Senbanjo IO, Ojo I. Incidence and cost estimate of treating pediatric adverse drug reactions in Lagos, Nigeria. Sao Paulo Med J. 2011;129(3):153-164. Doi: 10.1590/ S1516-31802011000300006
11. 11.Aderemi-Williams RI, Awodele O, Boyle CO. Adverse drug reactions amongst adult patients admitted in Lagos State University Teaching Hospital Lagos, Nigeria. Curr Drug Saf. 2015;10(2):136-144. Doi: 10.2174/15 7488631002150723105156 doi:10.2174/15
12. 12.Adedeji WA, Adegoke AB, Fehintola FA. ADRs reporting practice and associated factors among community health extension workers in public health facilities, Southwest, Nigeria. Pan Afr Med J. 2021;17(40):165. Doi: 10.11604/pamj.2021.40.165.28574 doi:10.11604/pamj.2021.40.165.28574
13. 13.Adisa R, Omitogun TI. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria. BMC Health Serv Res. 2019;19(1):926. Doi: 10.1186/s12913-019-4789-5 doi:10.1186/s12913-019-4789-5
14. 14.Krejcie RV, Morgan DW. Determining Sample Size for Research Activities. Educ Psychol Meas. 1970;30(3):607-610. Doi: 10.1177/001316447003000308 doi:10.1177/001316447003000308
15. 15.Belete KA, Tessema TB. Health Care Professionals’ Knowledge, Atti- 26 Majmaah Journal of Health Sciences ,Vol.13, Issue1 , January-2025,Rajab -1446 Knowledge and Practice of Adverse Drugs ReactionReportingAmongHealthCarePractitionersinPrimaryHealthCareCentersinKano Metropolis tude, and Practice towards ADR Reporting and Associated Factors at Selected Public Hospitals in Northeast Ethiopia: A Cross-Sectional Study. BioMed Res Int. 2019;2019:8690546. Doi: 10.1155/2019/8690546 doi:10.1155/2019/8690546
16. 16.Sharif MJH, Farrukh MJ, Khan FU, Khan Q, Ahmed SS, Kousar R, et al. Exploring the factors and barriers of healthcare professionals in tertiary care hospitals toward pharmacovigilance: a multicenter study from Khyber Pakhtunkhwa, Pakistan. Curr Med Res Opin. 2022;38(4):595-605. Doi: 10.1080/03007995.2022.2042992 doi:10.1080/03007995.2022.2042992
17. 17.Hu W, Tao Y, Lu Y. Knowledge, Attitude and Practice of Hospital Pharmacists in Central China Towards ADR Reporting: A Multicenter Cross‐Sectional Study. Front Pharmacol. 2022;13:823944. Doi: 10.3389/ fphar.2022.823944
18. 18.Tekel MT, Bekalu AF, Sema FD. Knowledge, Attitude, and Practice of Medical, Pharmacy, and Nursing Students Towards Pharmacovigilance and ADR Reporting at University of Gondar College of Medicine and Health Sciences, Northwest Ethiopia: A Cross-Sectional Study. Adv Med Educ Pract. 2021;12:1129-1139. Doi: 10.2147/AMEP.S327739 doi:10.2147/AMEP.S327739
19. 19.Nadew SS, Beyene KG, Beza SW. ADR reporting practice and associated factors among medical doctors in government hospitals in Addis Ababa, Ethiopia. PLoS ONE. 2020;15(1):e0227712. Doi: 10.1371/ journal.pone.0227712
20. 20.IsaPAC,GeevenNT,JessurunATM. Barriers and facilitators for systematically registering ADRs in electronic health records: a qualitative study with Dutch healthcare professionals.Expert Opin Drug Saf. 2022;21(5):699-706. Doi:10.1080/14740338.2022.2020756 doi:10.1080/14740338.2022.2020756
21. 21.Khan LM. Comparative epidemiology of hospital-acquired ADRs in adults and children and their impact on cost and hospital stay–a systematic review. Eur J Clin Pharmacol. 2013;69(12):1985-1996.Doi:10.1007/ s00228-013-1576-4
22. 22.Haines HM, Meyer JC, Summers RS, Godman BB. Knowledge, attitudes and practices of health care professionals towards ADR reporting in public sector PHCs in a South African district. Eur J Clin Pharmacol. 2020;76:991-1001. Doi: 10.1007/ s00228-020-02862-8